Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
Bioengineered|September 21, 2021
Long intergenic non-protein coding RNA 02570 promotes nasopharyngeal carcinoma progression by adsorbing microRNA miR-4649-3p thereby upregulating both sterol regulatory element binding protein 1, and fatty acid synthaseFei Liu, Jiazhang Wei, Yanrong Hao, et al.The Plant Journal : for Cell and Molecular Biology|November 3, 2024
Genome-wide associated study identifies FtPMEI13 gene conferring drought resistance in Tartary buckwheatJiayue He, Yanrong Hao, Yuqi He, et al.Biomed Research International|July 17, 2019
Long Noncoding RNAs and Messenger RNAs Expression Profiles Potentially Regulated by ZBTB7A in Nasopharyngeal CarcinomaFei Liu, Jiazhang Wei, Yanrong Hao, et al.The Lancet. Respiratory Medicine|June 6, 2022
Furmonertinib (AST2818) versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic EGFR mutation-positive non-small-cell lung cancer (FURLONG): a multicentre, double-blind, randomised phase 3 studyYuankai Shi, Gongyan Chen, Xiang Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 6, 2022
Central Nervous System Efficacy of Furmonertinib (AST2818) Versus Gefitinib as First-Line Treatment for EGFR-Mutated NSCLC: Results From the FURLONG StudyYuankai Shi, Gongyan Chen, Xiang Wang, et al.The Lancet Regional Health. Western Pacific|July 12, 2024
Patient-reported outcomes for the phase 3 FURLONG study of furmonertinib versus gefitinib as first-line therapy for Chinese patients with locally advanced or metastatic <i>EGFR</i> mutation-positive non-small cell lung cancerYuankai Shi, Gongyan Chen, Xiang Wang, et al.Innovation (Cambridge (Mass.))|March 18, 2025
Manipulation of a strigolactone transporter in tomato confers resistance to the parasitic weed broomrapeXinwei Ban, Li Qin, Jijun Yan, et al.Cell|November 5, 2024
Regulatory mechanisms of strigolactone perception in riceQingliang Hu, Huihui Liu, Yajun He, et al.The Lancet. Respiratory Medicine|December 7, 2025
First-line serplulimab plus chemotherapy with or without HLX04 versus chemotherapy in locally advanced or metastatic non-squamous non-small-cell lung cancer (ASTRUM-002): a randomised, double-blind, multicentre phase 3 trialLin Wang, Xuezhi Hao, Yanrong Hao, et al.European Journal of Psychotraumatology|April 11, 2022
Depression, anxiety and post-traumatic growth among COVID-19 survivors six-month after dischargeXin Xiao, Xue Yang, Weiran Zheng, et al.Pageof 5